Skip to content
  • Sunday, 26 July 2026
  • 3:36 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Oregon State University Researchers Unveil Real-Time Breakthrough in Alzheimer’s Protein Clumping Dynamics
Neuroscience & Brain Research

Oregon State University Researchers Unveil Real-Time Breakthrough in Alzheimer’s Protein Clumping Dynamics

Rifan Muazin Apr 24, 2026 0

The pursuit of a definitive treatment for Alzheimer’s disease has long been hindered by the microscopic complexity of the human…

Read More
Neuroscience & Brain Research

Lifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Onset and Slower Mental Decline

Rifan Muazin Apr 22, 2026 0

A comprehensive study published in the medical journal of the American Academy of Neurology, Neurology, has revealed a profound correlation…

Read More
Clinical Diagnostics & Pathology

Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs

Reynand Amr Wu Apr 22, 2026 0

A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…

Read More
Neuroscience & Brain Research

Immune System Response in the Brain Identified as Primary Cause for Early Olfactory Loss in Alzheimer’s Disease

Rifan Muazin Apr 19, 2026 0

A groundbreaking study conducted by researchers at the German Center for Neurodegenerative Diseases (DZNE) and Ludwig-Maximilians-Universität München (LMU) has revealed…

Read More
Pharmaceutical R&D

Cochrane Review Challenges Clinical Significance of Anti-Amyloid Alzheimer’s Drugs, Pharmaceutical Companies Reaffirm Efficacy

Teuku Ryan Apr 18, 2026 0

A comprehensive review of 17 clinical trials by the esteemed Cochrane organization has cast doubt on the clinically meaningful benefits…

Read More
Neuroscience & Brain Research

Hydrogen Sulfide and CSE Protein Research Offers New Therapeutic Target for Alzheimer’s Disease Treatment and Brain Health

Rifan Muazin Apr 17, 2026 0

Researchers at Johns Hopkins Medicine have announced that a newly funded study by the National Institutes of Health (NIH) is…

Read More
Neuroscience & Brain Research

Scientists just watched Alzheimer’s damage happen in real time

Rifan Muazin Apr 16, 2026 0

In a landmark study that bridges the gap between fundamental chemistry and clinical neurology, a research team at Oregon State…

Read More
Neuroscience & Brain Research

Lifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Disease and Cognitive Decline

Rifan Muazin Apr 15, 2026 0

Engaging in mentally stimulating activities across a person’s entire lifespan—ranging from childhood reading habits to learning new languages and playing…

Read More
Clinical Diagnostics & Pathology

Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs

Reynand Amr Wu Apr 15, 2026 0

A groundbreaking new longitudinal study, published April 1, 2026, in Neurology Open Access, an official journal of the American Academy…

Read More
Neuroscience & Brain Research

Brain Immune Response Linked to Early Loss of Smell in Alzheimer’s Disease Patients

Rifan Muazin Apr 11, 2026 0

The loss of the sense of smell, or anosmia, has long been documented as one of the most frequent and…

Read More

Posts pagination

1 … 6 7 8 9
Breakthrough in IVF Research Uses Oviduct Glycans to Extend Sperm Viability and Improve Embryo Success RatesCan live cell dynamics fix drug discovery’s efficacy problem?Innovative Housing Designs Dramatically Reduce Childhood Illnesses in TanzaniaThe Discovery Deepens a Mystery Over How Black Holes Grew So Big So Early in the Universe
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ